Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hand-Foot Syndrome × mecobalamin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hand-Foot Syndrome 1 Breast Neoplasms 1

Interventions

tegafur-gimeracil-oteracil 1 mecobalamin 1 S 1 (combination) 1 Pyridoxine 1 Celecoxib 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05165069 2026-02-02

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Active not recruiting

Breast Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡